Global Point of Care

Troponin Essentials: Implementing the Guidelines



The detection of a rise and/or fall of cardiac troponin plays a key role in identification of patients suspected of having an Acute Coronary Syndrome (ACS) and earlier diagnosis of myocardial infarction. However, individuals with non-ACS conditions can also have elevated cardiac troponin and many symptoms associated with non-ACS conditions may overlap with symptoms of ACS1. This presents a diagnostic challenge to the clinician and often requires an extended evaluation before the clinician can make an accurate diagnosis, which can impact efficiency and quality of care. This webinar will share an evidence-based approach to diagnosis and treatment of the ACS patient, with a focus on the current guidelines for troponin testing.

  1. Identify guideline-driven best practice recommendations on the use of biomarkers in the treatment of Acute Coronary Syndrome (ACS)
  2. Review updates to the Myocardial Infarction (MI) Definition and Non-ST elevation Acute Coronary Syndromes (NSTE-ACS) guidelines
  3. Discuss troponin turn-around-time (TAT) recommendations and documentation requirements
  4. Share quality practices that optimize the care and outcomes of ACS patients

This event is produced by Whitehat Communications and sponsored 
by Abbott Point of Care.

1. Third Universal Definition of Myocardial Infarction (MI), Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe, Maarten L. Simoons, Bernard R. Chaitman and Harvey D. White, Circulation 2012;126:2020-2035  

About Presenter

In January 2009, Ruth Cantu joined the Society of Cardiovascular Patient Care which merged with the American College of Cardiology in 2016. Ruth has been in nursing for 24 years and received her Bachelor of Science in Nursing from the University of Texas San Antonio School of Nursing. She has a background including Cardiovascular Operating Room as well as Transplant Coordination and Education and tissue transplant program development.

Ruth worked in the Laboratory Diagnostics field as a Clinical Specialist. While in the diagnostics field, her role enabled Ruth to work with Emergency Departments, Chest Pain Centers and Laboratories to educate and facilitate process improvement, workflow development and assist in developing methods to improve turn-around-times and streamline processes of care.

In February of 2016 she transitioned to the role of Program Manager in addition to continuing to maintain her role as the laboratory diagnostics liaison and Accreditation Review Specialist. Ruth continues to serve as the key contact and facilitator to all major laboratory diagnostics vendors, as well as hospitals, to advise them on the latest guideline practice recommendations and provide education for diagnostic related criteria. She has presented talks for the American Association of Clinical Chemistry and the College of American Pathologists as well as various national webinars.